About Syneron Medical
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company designs, develops and markets aesthetic medical products based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. Its products target an array of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: ELOS
- Previous Close: $9.95
- 50 Day Moving Average: $9.27
- 200 Day Moving Average: $7.91
- 52-Week Range: $6.18 - $10.85
- Trailing P/E Ratio: 1990.00
- Foreward P/E Ratio: 17.50
- P/E Growth: 0.68
- Market Cap: $345.36M
- Outstanding Shares: 34,710,000
- Beta: 1.1
- Net Margins: 1.04%
- Return on Equity: 3.15%
- Return on Assets: 2.34%
Companies Related to Syneron Medical:
- Current Ratio: 2.94%
- Quick Ratio: 2.19%
What is Syneron Medical's stock symbol?
Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."
Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?
2 analysts have issued 1-year price objectives for Syneron Medical's shares. Their predictions range from $7.80 to $13.00. On average, they expect Syneron Medical's stock price to reach $10.40 in the next year.
When will Syneron Medical announce their earnings?
Syneron Medical is scheduled to release their next quarterly earnings announcement on Wednesday, May, 17th 2017.
Who owns Syneron Medical stock?
Syneron Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include
BRANDES INVESTMENT PARTNERS, LP
(10.55%), Renaissance Technologies LLC (3.29%), Menora Mivtachim Holdings LTD. (1.48%), Perritt Capital Management Inc. (1.22%), Kenmare Capital Partners L.L.C. (0.78%) and Two Sigma Investments LP (0.68%).
Who sold Syneron Medical stock? Who is selling Syneron Medical stock?
Syneron Medical's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP.
Who bought Syneron Medical stock? Who is buying Syneron Medical stock?
Syneron Medical's stock was bought by a variety of institutional investors in the last quarter, including Kenmare Capital Partners L.L.C., Renaissance Technologies LLC, Two Sigma Investments LP, Clough Capital Partners L P, Bogle Investment Management L P DE, Oxford Asset Management, Russell Investments Group Ltd. and Boothbay Fund Management LLC.
How do I buy Syneron Medical stock?
Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Syneron Medical stock cost?
One share of Syneron Medical stock can currently be purchased for approximately $9.80.